Kestra Investment Management LLC Acquires New Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Kestra Investment Management LLC acquired a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 16,951 shares of the real estate investment trust’s stock, valued at approximately $690,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in OHI. Daiwa Securities Group Inc. raised its stake in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after purchasing an additional 3,003,845 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after purchasing an additional 1,274,238 shares in the last quarter. Marshall Wace LLP bought a new stake in Omega Healthcare Investors during the second quarter valued at approximately $20,962,000. FMR LLC grew its stake in Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 0.1 %

Shares of Omega Healthcare Investors stock opened at $40.61 on Monday. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $44.42. The company’s 50 day moving average price is $40.61 and its 200-day moving average price is $37.40. The stock has a market capitalization of $10.96 billion, a price-to-earnings ratio of 29.86, a P/E/G ratio of 1.26 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.60%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on OHI shares. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. BMO Capital Markets upped their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a research report on Thursday, October 31st. Scotiabank upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $40.00.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.